PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
116.11%
Net income growth above 1.5x CRON.TO's 15.51%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
21.06%
Less D&A growth vs. CRON.TO's 69.57%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
530.30%
Deferred tax of 530.30% while CRON.TO is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
-187.47%
Both cut yoy SBC, with CRON.TO at -9.26%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
-193.28%
Both reduce yoy usage, with CRON.TO at -155.59%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-164.72%
Both yoy AR lines negative, with CRON.TO at -108.73%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-1036.63%
Both reduce yoy inventory, with CRON.TO at -118.05%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
205.25%
AP growth well above CRON.TO's 275.20%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
-267.07%
Both reduce yoy usage, with CRON.TO at -2636.58%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-111.49%
Both negative yoy, with CRON.TO at -8.56%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
9996.05%
Some CFO growth while CRON.TO is negative at -14.16%. John Neff would note a short-term liquidity lead over the competitor.
-30.06%
Negative yoy CapEx while CRON.TO is 77.37%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
2410.18%
Acquisition spending well above CRON.TO's 63.18%. Michael Burry would suspect heavier integration risk or short-term free cash flow drain vs. competitor.
48.73%
Some yoy expansion while CRON.TO is negative at -41.67%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
-95.97%
We reduce yoy sales while CRON.TO is 19827.54%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
5928.18%
Growth well above CRON.TO's 345.35%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
2602.75%
Investing outflow well above CRON.TO's 2314.48%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
-1408.93%
We cut debt repayment yoy while CRON.TO is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
30700.49%
Issuance growth of 30700.49% while CRON.TO is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
No Data
No Data available this quarter, please select a different quarter.